Hubei Hongyuan Pharmaceutical Technology Co., Ltd. (SHE:301246)
China flag China · Delayed Price · Currency is CNY
21.07
-0.33 (-1.54%)
At close: Jan 30, 2026

SHE:301246 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jan '26 Dec '24 Dec '23 Jan '23 Jan '22 Jan '21
8,4245,38510,392---
Market Cap Growth
61.94%-48.18%----
Enterprise Value
7,7074,0688,758---
Last Close Price
21.2313.5025.83---
PE Ratio
592.31104.64119.22---
PS Ratio
4.773.045.06---
PB Ratio
1.941.242.38---
P/TBV Ratio
2.031.292.49---
P/OCF Ratio
--294.81---
EV/Sales Ratio
4.372.304.26---
EV/EBITDA Ratio
39.5219.1039.79---
EV/EBIT Ratio
-115.30136.98---
Debt / Equity Ratio
0.150.090.080.210.050.13
Debt / EBITDA Ratio
3.331.751.581.240.180.37
Debt / FCF Ratio
-----1.85
Asset Turnover
0.300.310.430.650.750.77
Inventory Turnover
6.026.886.674.402.892.57
Quick Ratio
1.972.353.200.931.011.15
Current Ratio
2.912.683.501.261.671.87
Return on Equity (ROE)
0.31%1.18%2.69%22.93%34.51%24.35%
Return on Assets (ROA)
0.00%0.38%0.84%5.18%10.62%13.04%
Return on Invested Capital (ROIC)
0.01%1.16%2.46%12.86%23.80%28.10%
Return on Capital Employed (ROCE)
0.00%0.80%1.40%10.20%19.60%28.10%
Earnings Yield
0.17%0.96%0.84%---
FCF Yield
-3.97%-3.27%-4.23%---
Dividend Yield
0.14%0.22%0.19%---
Payout Ratio
179.39%59.97%61.72%3.44%0.45%3.40%
Buyback Yield / Dilution
1.24%-2.71%-10.02%0.00%-0.13%0.12%
Total Shareholder Return
1.38%-2.49%-9.83%0.00%-0.13%0.12%
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.